286 related articles for article (PubMed ID: 33289964)
1. Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.
Soni M
Int J Lab Hematol; 2021 Jul; 43 Suppl 1():137-141. PubMed ID: 33289964
[TBL] [Abstract][Full Text] [Related]
2. Eosinopenia <100/μL as a marker of active COVID-19: An observational prospective study.
Outh R; Boutin C; Gueudet P; Suzuki M; Saada M; Aumaître H
J Microbiol Immunol Infect; 2021 Feb; 54(1):61-68. PubMed ID: 33468435
[TBL] [Abstract][Full Text] [Related]
3. A study to evaluate the role of eosinophil count as a prognostic marker for assessing the outcome in patients with COVID 19 infection.
P P; Krishnamurthy V; Kumar TA
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443507
[TBL] [Abstract][Full Text] [Related]
4. Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.
Cortés-Vieyra R; Gutiérrez-Castellanos S; Álvarez-Aguilar C; Baizabal-Aguirre VM; Nuñez-Anita RE; Rocha-López AG; Gómez-García A
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578258
[TBL] [Abstract][Full Text] [Related]
5. A study to evaluate the role of eosinophil count as a prognostic marker for assessing the outcome in patients with COVID-19 infection.
Krishnamurthy V; Sujatha KJ; Kumar TA; Phaniraj P; Shankar T; Raj MP
Ann Afr Med; 2022; 21(3):278-282. PubMed ID: 36204916
[TBL] [Abstract][Full Text] [Related]
6. Eosinophil count (EC) as a diagnostic and prognostic marker for infection in the internal medicine department setting.
Karakonstantis S; Gryllou N; Papazoglou G; Lydakis C
Rom J Intern Med; 2019 Jun; 57(2):166-174. PubMed ID: 30517081
[TBL] [Abstract][Full Text] [Related]
7. The role of eosinophil as a diagnostic, differential, and prognostic marker for Covid-19 during pregnancy: Case-control study from tertiary center.
Atalay A; Sinaci S; Besimoglu B; Ozkavak O; Kaya E; Kara O; Sahin D
J Obstet Gynaecol Res; 2023 Aug; 49(8):2063-2072. PubMed ID: 37309016
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic utility of WBC counts and cell population data in patients with COVID-19.
Naoum FA; Ruiz ALZ; Martin FHO; Brito THG; Hassem V; Oliveira MGL
Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):124-128. PubMed ID: 33190400
[TBL] [Abstract][Full Text] [Related]
9. Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients.
Valverde-Monge M; Cañas JA; Barroso B; Betancor D; Ortega-Martin L; Gómez-López A; Rodríguez-Nieto MJ; Mahíllo-Fernández I; Sastre J; Del Pozo V
Front Immunol; 2021; 12():668074. PubMed ID: 34149705
[TBL] [Abstract][Full Text] [Related]
10. Eosinopenia is a reliable marker of severe disease and unfavourable outcome in patients with COVID-19 pneumonia.
Cazzaniga M; Fumagalli LAM; D'angelo L; Cerino M; Bonfanti G; Fumagalli RM; Schiavo G; Lorini C; Lainu E; Terragni S; Chiarelli M; Scarazzati C; Bonato C; Zago M
Int J Clin Pract; 2021 Jul; 75(7):e14047. PubMed ID: 33497517
[TBL] [Abstract][Full Text] [Related]
11. Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units.
Abidi K; Khoudri I; Belayachi J; Madani N; Zekraoui A; Zeggwagh AA; Abouqal R
Crit Care; 2008; 12(2):R59. PubMed ID: 18435836
[TBL] [Abstract][Full Text] [Related]
12. Persistent eosinopenia is associated with in-hospital mortality among older patients: unexpected prognostic value of a revisited biomarker.
Partouche B; Pepin M; de Farcy PM; Kahn JE; Sawczynski B; Lechowski L; Teillet L; Barbot F; Herr M; Davido B
BMC Geriatr; 2021 Oct; 21(1):557. PubMed ID: 34649512
[TBL] [Abstract][Full Text] [Related]
13. Eosinopenia as a diagnostic marker of bloodstream infection in hospitalised paediatric and adult patients: a case-control study.
Wibrow BA; Ho KM; Flexman JP; Keil AD; Kohrs DL
Anaesth Intensive Care; 2011 Mar; 39(2):224-30. PubMed ID: 21485670
[TBL] [Abstract][Full Text] [Related]
14. Eosinopenia in COVID-19: What we missed so far?
Davido B; Partouche B; Jaffal K; de Truchis P; Herr M; Pepin M
J Microbiol Immunol Infect; 2021 Oct; 54(5):1006-1007. PubMed ID: 33648873
[No Abstract] [Full Text] [Related]
15. Early Prediction of Severe COVID-19 in Patients by a Novel Immune-Related Predictive Model.
Sun C; Xue M; Yang M; Zhu L; Zhao Y; Lv X; Lin Y; Ma D; Shen X; Cheng Y; Xuan H; Jia X; Li T; Han L
mSphere; 2021 Oct; 6(5):e0075221. PubMed ID: 34643417
[TBL] [Abstract][Full Text] [Related]
16. Prognostic usefulness of eosinopenia in the pediatric intensive care unit.
Kim YH; Park HB; Kim MJ; Kim HS; Lee HS; Han YK; Kim KW; Sohn MH; Kim KE
J Korean Med Sci; 2013 Jan; 28(1):114-9. PubMed ID: 23341721
[TBL] [Abstract][Full Text] [Related]
17. Original Article: Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.
Soni M
Int J Lab Hematol; 2021 Dec; 43(6):e303. PubMed ID: 33973726
[No Abstract] [Full Text] [Related]
18. Coronavirus disease 2019 and peripheral blood eosinophil counts: a retrospective study.
Eijmael M; Janssens N; le Cessie S; van Dooren Y; Koster T; Karim F
Infection; 2021 Dec; 49(6):1325-1329. PubMed ID: 34625911
[TBL] [Abstract][Full Text] [Related]
19. Eosinopenia in COVID-19 Patients: A Retrospective Analysis.
Ndieugnou Djangang N; Peluso L; Talamonti M; Izzi A; Gevenois PA; Garufi A; Goffard JC; Henrard S; Severgnini P; Vincent JL; Creteur J; Taccone FS
Microorganisms; 2020 Dec; 8(12):. PubMed ID: 33291791
[No Abstract] [Full Text] [Related]
20. Do Blood Eosinophils Predict in-Hospital Mortality or Severity of Disease in SARS-CoV-2 Infection? A Retrospective Multicenter Study.
Le Borgne P; Abensur Vuillaume L; Alamé K; Lefebvre F; Chabrier S; Bérard L; Haessler P; Gennai S; Bilbault P; Lavoignet CE
Microorganisms; 2021 Feb; 9(2):. PubMed ID: 33567583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
